(Q43766103)

26 November 2017

title

Inhaled antibiotics in cystic fibrosis: is there a therapeutic effect? (English)

1 reference

26 November 2017

0 references

0 references

MacLusky I

1

1 reference

26 November 2017

Levison H

series ordinal

2

1 reference

26 November 2017

Gold R

series ordinal

3

1 reference

26 November 2017

McLaughlin FJ

series ordinal

4

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 May 1986

1 reference

The Journal of Pediatrics

26 November 2017

published in

1 reference

26 November 2017

volume

108

1 reference

26 November 2017

issue

5 Pt 2

1 reference

26 November 2017

page(s)

861-865

1 reference

The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980758-2

Penetration of antibiotics into respiratory secretions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980758-2

Clinical and Bacteriological Responses to Three Antibiotic Regimens for Acute Exacerbations of Cystic Fibrosis: Tlcarcillln-Tobramycin, Azlocillin-Tobramycin, and Azlocillin-Placebo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980758-2

Bacterial Flora of Respiratory Tract in Patients with Cystic Fibrosis, 1950-1971

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980758-2

Sputum bacteriology in patients with cystic fibrosis in a Toronto hospital during 1970-1981

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980758-2

Antibiotic prophylaxis in cystic fibrosis: inhaled cephaloridine as an adjunct to oral cloxacillin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980758-2

Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980758-2

Aerosols and humidity therapy. Generation and respiratory deposition of therapeutic aerosols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980758-2

Pulmonary deposition of aerosols in children with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980758-2

Ventilatory effects of aerosol gentamicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980758-2

The art and science of the use of antibiotics in cystic fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980758-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Efficacy of inhaled tobramycin in the treatment of pulmonary exacerbations in children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2980758-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(86)80758-2

1 reference

26 November 2017

1 reference